119 related articles for article (PubMed ID: 23849583)
1. Validation of the Brazilian version of the Expanded Prostate Cancer Index Composite (EPIC) for patients submitted to radical prostatectomy.
Alves E; Medina R; Andreoni C
Int Braz J Urol; 2013; 39(3):344-52. PubMed ID: 23849583
[TBL] [Abstract][Full Text] [Related]
2. The German version of the Expanded Prostate Cancer Index Composite (EPIC): translation, validation and minimal important difference estimation.
Umbehr MH; Bachmann LM; Poyet C; Hammerer P; Steurer J; Puhan MA; Frei A
Health Qual Life Outcomes; 2018 Feb; 16(1):36. PubMed ID: 29458434
[TBL] [Abstract][Full Text] [Related]
3. RE: Validation of the brazilian version of the expanded prostate cancer index composite (EPIC) for patients submitted to radical prostatectomy.
Heldwein FL; Traebert JL; Hartmann AA; Pioner GT; Teloken C
Int Braz J Urol; 2015; 41(3):604-5. PubMed ID: 26200562
[No Abstract] [Full Text] [Related]
4. Validation of the Italian version of the abbreviated expanded prostate Cancer index composite (EPIC-26) in men with prostate Cancer.
Marzorati C; Monzani D; Mazzocco K; Masiero M; Pavan F; Monturano M; Pravettoni G
Health Qual Life Outcomes; 2019 Aug; 17(1):147. PubMed ID: 31464649
[TBL] [Abstract][Full Text] [Related]
5. Portuguese version of the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP): psychometric validation and prospective application for early functional outcomes at a single institution.
Lourenço DB; Amaral BS; Alfer-Junior W; Vasconcellos A; Russo F; Sanchez-Salas R; Bianco B; Wagner AA; Chang P; Moschovas MC; Lemos GC; Carneiro A
BMC Urol; 2020 Oct; 20(1):163. PubMed ID: 33081748
[TBL] [Abstract][Full Text] [Related]
6. Cross-cultural adaptation and validation of the French version of the Expanded Prostate cancer Index Composite questionnaire for health-related quality of life in prostate cancer patients.
Anota A; Mariet AS; Maingon P; Joly F; Bosset JF; Guizard AV; Bittard H; Velten M; Mercier M
Health Qual Life Outcomes; 2016 Dec; 14(1):168. PubMed ID: 27923377
[TBL] [Abstract][Full Text] [Related]
7. Clinical Use of Expanded Prostate Cancer Index Composite for Clinical Practice to Assess Patient Reported Prostate Cancer Quality of Life Following Robot-Assisted Radical Prostatectomy.
Wagner AA; Cheng PJ; Carneiro A; Dovirak O; Khosla A; Taylor KN; Crociani CM; McAnally KC; Percy A; Dewey LE; Sanda MG; Chang P
J Urol; 2017 Jan; 197(1):109-114. PubMed ID: 27475967
[TBL] [Abstract][Full Text] [Related]
8. Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy.
Hedgepeth RC; Labo J; Zhang L; Wood DP
J Urol; 2009 Jul; 182(1):221-7; discussion 227-8. PubMed ID: 19450842
[TBL] [Abstract][Full Text] [Related]
9. [Quality of life in patients with prostate cancer: validation of an instrument for clinical practice].
Balbontín F; Marchetti P; Moreno S; Cabello JM; Urzúa C; Silva A; Avilés J; Badínez L; García J; Salgado A; Vinez E; Alliende I; Canals A; Velasco A
Arch Esp Urol; 2015 Jun; 68(5):466-73. PubMed ID: 26102050
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life in men with localized prostate cancer treated with radiotherapy: validation of an abbreviated version of the Expanded Prostate Cancer Index Composite for Clinical Practice in Spain.
Zapatero A; Maldonado Pijoan X; Gómez-Caamaño A; Pardo Masferrer J; Macías Hernández V; Hervás Morón A; Muñoz García JL; Palacios Eito A; Anguita-Alonso P; González-Junco C; López Torrecilla J
Health Qual Life Outcomes; 2021 Sep; 19(1):223. PubMed ID: 34563208
[TBL] [Abstract][Full Text] [Related]
11. Psychometric testing of the Norwegian version of the Expanded Prostate Cancer Index Composite 26-item version (EPIC-26).
Fosså SD; Storås AH; Steinsvik EA; Myklebust TA; Eri LM; Loge JH; Dahl AA
Scand J Urol; 2016 Aug; 50(4):280-5. PubMed ID: 27049891
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the quality of life of patients with localizad prostate cancer: validation of the Spanish version of the EPIC].
Ferrer M; Garin O; Pera J; Prats JM; Mendivil J; Alonso J; De Paula B; Herruzo I; Hervas A; Macias V; Mariño A; Ortiz MJ; Pastor S; Ponce De León J; Sancho G;
Med Clin (Barc); 2009 Feb; 132(4):128-35. PubMed ID: 19211071
[TBL] [Abstract][Full Text] [Related]
13. Prospective longitudinal outcomes of quality of life after laparoscopic radical prostatectomy compared with retropubic radical prostatectomy.
Hashine K; Kakuda T; Iuchi S; Hosokawa T; Ninomiya I
Health Qual Life Outcomes; 2018 Jan; 16(1):7. PubMed ID: 29304808
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
[TBL] [Abstract][Full Text] [Related]
15. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study.
Yaxley JW; Coughlin GD; Chambers SK; Occhipinti S; Samaratunga H; Zajdlewicz L; Dunglison N; Carter R; Williams S; Payton DJ; Perry-Keene J; Lavin MF; Gardiner RA
Lancet; 2016 Sep; 388(10049):1057-1066. PubMed ID: 27474375
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of the korean version of expanded prostate cancer index composite: questionnaire assessing health-related quality of life after prostate cancer treatment.
Chung KJ; Kim JJ; Lim SH; Kim TH; Han DH; Lee SW
Korean J Urol; 2010 Sep; 51(9):601-12. PubMed ID: 20856644
[TBL] [Abstract][Full Text] [Related]
17. Psychometric properties of the expanded prostate cancer index composite - 26 instrument in a cohort of radical prostatectomy patients: theoretical and practical examinations.
Axcrona K; Nilsson R; Brennhovd B; Sørebø Ø; Fosså SD; Dahl AA
BMC Urol; 2017 Dec; 17(1):111. PubMed ID: 29197360
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life after robot-assisted radical prostatectomy compared with laparoscopic radical prostatectomy.
Koike H; Kohjimoto Y; Iba A; Kikkawa K; Yamashita S; Iguchi T; Matsumura N; Hara I
J Robot Surg; 2017 Sep; 11(3):325-331. PubMed ID: 28130703
[TBL] [Abstract][Full Text] [Related]
19. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.
Ferrer M; Guedea F; Suárez JF; de Paula B; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Boladeras A; Ayala A; Craven-Bratle J; Ávila M; Cunillera O; Pardo Y; Alonso J; Aguiló F;
Radiother Oncol; 2013 Aug; 108(2):306-13. PubMed ID: 23849168
[TBL] [Abstract][Full Text] [Related]
20. Psychometric validation of the German version of the EPIC-26 questionnaire for patients with localized and locally advanced prostate cancer.
Sibert NT; Dieng S; Oesterle A; Feick G; Carl G; Steiner T; Minner J; Roghmann F; Kaftan B; Zengerling F; Hinkel A; Beyer B; Heidenreich A; Harke N; Brehmer B; Pfitzenmaier J; Fichtner J; Neisius A; Hammerer P; Wesselmann S; Kowalski C
World J Urol; 2021 Jan; 39(1):11-25. PubMed ID: 31552467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
